{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:49:17Z","timestamp":1792180157662,"version":"4.4.0"},"reference-count":137,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Tenascins are a family of multifunctional extracellular matrix (ECM) glycoproteins with time- and tissue specific expression patterns during development, tissue homeostasis, and diseases. There are four family members (tenascin-C, -R, -X, -W) in vertebrates. Among them, tenascin-X (TNX) and tenascin-C (TNC) play important roles in human pathologies. TNX is expressed widely in loose connective tissues. TNX contributes to the stability and maintenance of the collagen network, and its absence causes classical-like Ehlers-Danlos syndrome (clEDS), a heritable connective tissue disorder. In contrast, TNC is specifically and transiently expressed upon pathological conditions such as inflammation, fibrosis, and cancer. There is growing evidence that TNC is involved in inflammatory processes with proinflammatory or anti-inflammatory activity in a context-dependent manner. In this review, we summarize the roles of these two tenascins, TNX and TNC, in cardiovascular and inflammatory diseases and in clEDS, and we discuss the functional consequences of the expression of these tenascins for tissue homeostasis.<\/jats:p>","DOI":"10.3389\/fimmu.2020.609752","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T06:58:47Z","timestamp":1606805927000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":58,"title":["The Roles of Tenascins in Cardiovascular, Inflammatory, and Heritable Connective Tissue Diseases"],"prefix":"10.3389","volume":"11","author":[{"given":"Ken-ichi","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1242\/dev.117.4.1183","article-title":"Regulation of development and differentiation by the extracellular matrix","volume":"117","author":"Adams","year":"1993","journal-title":"Development"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a004960","article-title":"Tenascins and the importance of adhesion modulation","volume":"3","author":"Chiquet-Ehrismann","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4161\/19336918.2014.970030","article-title":"The evolution of tenascins and fibronectin","volume":"9","author":"Adams","year":"2015","journal-title":"Cell Adh Migr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2008.12.012","article-title":"The regulation of tenascin expression by tissue microenvironments","volume":"1793","author":"Tucker","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2014.01.007","article-title":"Tenascins in stem cell niches","volume":"37","author":"Chiquet-Ehrismann","year":"2014","journal-title":"Matrix Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-012-1446-0","article-title":"Tenascins and inflammation in disorders of the nervous system","volume":"44","author":"Jakovcevski","year":"2013","journal-title":"Amino Acids"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4161\/19336918.2014.994893","article-title":"Tenascin-X: beyond the architectural function","volume":"9","author":"Valcourt","year":"2015","journal-title":"Cell Adh Migr"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00053","article-title":"The expression and possible functions of tenascin-W during development and disease","volume":"7","author":"Tucker","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/path.1415","article-title":"Tenascins: regulation and putative functions during pathological stress","volume":"200","author":"Chiquet-Ehrismann","year":"2003","journal-title":"J Pathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/19336918.2015.1008333","article-title":"Transcriptional regulation of tenascin genes","volume":"9","author":"Chiovaro","year":"2015","journal-title":"Cell Adh Migr"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.130.3.503","article-title":"Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1","volume":"130","author":"Bornstein","year":"1995","journal-title":"J Cell Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/s0955-0674(02)00361-7","article-title":"Matricellular proteins: extracellular modulators of cell function","volume":"14","author":"Bornstein","year":"2002","journal-title":"Curr Opin Cell Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.125.2.483","article-title":"The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C","volume":"125","author":"Matsumoto","year":"1994","journal-title":"J Cell Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/aja.1002030411","article-title":"Embryonic expression of tenascin-X suggests a role in limb, muscle, and heart development","volume":"203","author":"Burch","year":"1995","journal-title":"Dev Dyn"},{"key":"B15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1432-1033.1995.tb20673.x","article-title":"Distinct tissue distribution in pigs of tenascin-X and tenascin-C transcripts","volume":"231","author":"Geffrotin","year":"1995","journal-title":"Eur J Biochem"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1101\/gad.6.10.1821","article-title":"Mice develop normally without tenascin","volume":"6","author":"Saga","year":"1992","journal-title":"Genes Dev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-0436.2003.7104506.x","article-title":"The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse","volume":"71","author":"Imanaka-Yoshida","year":"2003","journal-title":"Differentiation"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1089\/ten.2005.11.1618","article-title":"Brain-derived neurotrophic factor enhances periodontal tissue regeneration","volume":"11","author":"Takeda","year":"2005","journal-title":"Tissue Eng"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.109.8.2069","article-title":"Tenascin-X expression in tumor cells and fibroblasts: glucocorticoids as negative regulators in fibroblasts","volume":"109","author":"Sakai","year":"1996","journal-title":"J Cell Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.2006","article-title":"Transcription factor Sp1 activates the expression of the mouse tenascin-X gene","volume":"267","author":"Minamitani","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.09.046","article-title":"Genome-wide microRNA analysis implicates miR-30b\/d in the etiology of\u00a0alopecia areata","volume":"138","author":"Tafazzoli","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14161","article-title":"LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K\/Akt signalling pathway","volume":"23","author":"Yan","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.23812\/20-73-a-33","article-title":"Silencing LncRNA LINC01305 inhibits epithelial mesenchymal transition in lung cancer cells by regulating TNXB-mediated PI3K\/Akt signaling pathway","volume":"34","author":"Yan","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108036","article-title":"Differentially expressed circular RNAs in orbital adipose\/connective tissue from patients with thyroid-associated ophthalmopathy","volume":"196","author":"Wu","year":"2020","journal-title":"Exp Eye Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-002-0577-x","article-title":"Distribution of extracellular matrix tenascin-X in sciatic nerves","volume":"104","author":"Matsumoto","year":"2002","journal-title":"Acta Neuropathol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/ng0997-104","article-title":"Tenascin-X deficiency is associated with Ehlers-Danlos syndrome","volume":"17","author":"Burch","year":"1997","journal-title":"Nat Genet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"6569","DOI":"10.1038\/s41598-020-63499-2","article-title":"Mechanical allodynia in mice with tenascin-X deficiency associated with Ehlers-Danlos syndrome","volume":"10","author":"Okuda-Ashitaka","year":"2020","journal-title":"Sci Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.aanat.2008.04.003","article-title":"Novel localization of tenascin-X in adult mouse leptomeninges and choroid plexus","volume":"190","author":"Imura","year":"2008","journal-title":"Ann Anat"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.1236","article-title":"Tenascin-Y is concentrated in adult nerve roots and has barrier properties in vitro","volume":"66","author":"Tucker","year":"2001","journal-title":"J Neurosci Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181b6bde3","article-title":"Tenascin-X is a novel diagnostic marker of malignant mesothelioma","volume":"33","author":"Yuan","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13156","article-title":"Tenascin XB is a novel diagnostic marker for malignant mesothelioma","volume":"39","author":"Nakayama","year":"2019","journal-title":"Anticancer Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/208017","article-title":"Secretome identifies tenascin-X as a potent marker of ovarian cancer","volume":"2015","author":"Kramer","year":"2015","journal-title":"BioMed Res Int"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s004010050636","article-title":"Differential expression of tenascin-C and tenascin-X in human astrocytomas","volume":"93","author":"Hasegawa","year":"1997","journal-title":"Acta Neuropathol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/s0304-4165(00)00158-6","article-title":"Opposite regulation of tenascin-C and tenascin-X in MeLiM swine heritable cutaneous malignant melanoma","volume":"1524","author":"Geffrotin","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"B35","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1158\/1078-0432.Ccr-06-0182","article-title":"Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1","volume":"13","author":"L\u00e9vy","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23166","article-title":"A functional variant in TNXB promoter associates with the risk of esophageal squamous-cell carcinoma","volume":"59","author":"Yang","year":"2020","journal-title":"Mol Carcinog"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2443.2001.00482.x","article-title":"Tumour invasion and metastasis are promoted in mice deficient in tenascin-X","volume":"6","author":"Matsumoto","year":"2001","journal-title":"Genes Cells"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2004.03.041","article-title":"Induction of matrix metalloproteinase-2 by tenascin-X deficiency is mediated through the c-Jun N-terminal kinase and protein tyrosine kinase phosphorylation pathway","volume":"297","author":"Matsumoto","year":"2004","journal-title":"Exp Cell Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2002.tb02472.x","article-title":"Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C","volume":"93","author":"Matsumoto","year":"2002","journal-title":"Jpn J Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/ng850","article-title":"Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition","volume":"30","author":"Mao","year":"2002","journal-title":"Nat Genet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa002939","article-title":"A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency","volume":"345","author":"Schalkwijk","year":"2001","journal-title":"N Engl J Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/ajmg.c.30071","article-title":"Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome","author":"Bristow","year":"2005","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2008.11.038","article-title":"Nanomechanical properties of tenascin-X revealed by single-molecule force spectroscopy","volume":"385","author":"Jollymore","year":"2009","journal-title":"J Mol Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.bpc.2009.12.011","article-title":"Tenascin-X increases the stiffness of collagen gels without affecting fibrillogenesis","volume":"147","author":"Margaron","year":"2010","journal-title":"Biophys Chem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2006.10.037","article-title":"A model of tenascin-X integration within the collagenous network","volume":"580","author":"Lethias","year":"2006","journal-title":"FEBS Lett"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M603147200","article-title":"Collagen XII interacts with avian tenascin-X through its NC3 domain","volume":"281","author":"Veit","year":"2006","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-5793(01)02361-4","article-title":"Binding of tenascin-X to decorin","volume":"495","author":"Elefteriou","year":"2001","journal-title":"FEBS Lett"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2004.04.030","article-title":"Modulation of collagen fibrillogenesis by tenascin-X and type VI collagen","volume":"298","author":"Minamitani","year":"2004","journal-title":"Exp Cell Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-006-0706-9","article-title":"Interactions of human tenascin-X domains with dermal extracellular matrix molecules","volume":"298","author":"Egging","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.22401.x","article-title":"Deficiency of tenascin-X causes abnormalities in dermal elastic fiber morphology","volume":"122","author":"Zweers","year":"2004","journal-title":"J Invest Dermatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1524-475X.2010.00642.x","article-title":"Bioactive peptides derived from vascular endothelial cell extracellular matrices promote microvascular morphogenesis and wound healing in vitro","volume":"19","author":"Demidova-Rice","year":"2011","journal-title":"Wound Repair Regen"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2443.2000.00376.x","article-title":"Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation","volume":"5","author":"Ikuta","year":"2000","journal-title":"Genes Cells"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2017.06.003","article-title":"A potential contribution of tenascin-X to blood vessel formation in peripheral nerves","volume":"124","author":"Sakai","year":"2017","journal-title":"Neurosci Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13397","article-title":"Loss of tenascin X gene function impairs injury-induced stromal angiogenesis in mouse corneas","volume":"22","author":"Sumioka","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.03.134","article-title":"TNX deficiency results in bone loss due to an increase in multinucleated osteoclasts","volume":"512","author":"Kajitani","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201308031","article-title":"Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-\u03b2","volume":"205","author":"Alcaraz","year":"2014","journal-title":"J Cell Biol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.yexcr.2004.03.002","article-title":"Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen","volume":"297","author":"Minamitani","year":"2004","journal-title":"Exp Cell Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00723.2009","article-title":"Muscle characteristics and altered myofascial force transmission in tenascin-X-deficient mice, a mouse model of Ehlers-Danlos syndrome","volume":"109","author":"Huijing","year":"2010","journal-title":"J Appl Physiol (1985)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3109\/03008207.2010.551616","article-title":"Mild muscular features in tenascin-X knockout mice, a model of Ehlers-Danlos syndrome","volume":"52","author":"Voermans","year":"2011","journal-title":"Connect Tissue Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1080\/03008200601166160","article-title":"Wound healing in tenascin-X deficient mice suggests that tenascin-X is involved in matrix maturation rather than matrix deposition","volume":"48","author":"Egging","year":"2007","journal-title":"Connect Tissue Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2017.12.025","article-title":"Wound healing-related properties detected in an experimental model with a collagen gel contraction assay are affected in the absence of tenascin-X","volume":"363","author":"Hashimoto","year":"2018","journal-title":"Exp Cell Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1113\/jp276300","article-title":"The extracellular matrix glycoprotein tenascin-X regulates peripheral sensory and motor neurones","volume":"596","author":"Aktar","year":"2018","journal-title":"J Physiol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1113\/jp277195","article-title":"A novel role for the extracellular matrix glycoprotein-Tenascin-X in gastric function","volume":"597","author":"Aktar","year":"2019","journal-title":"J Physiol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-008-0591-y","article-title":"Analysis of obstetric complications and uterine connective tissue in tenascin-X-deficient humans and mice","volume":"332","author":"Egging","year":"2008","journal-title":"Cell Tissue Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.34.590","article-title":"Behavioral alterations in mice lacking the gene for tenascin-X","volume":"34","author":"Kawakami","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1356-9597.2004.00755.x","article-title":"Triglyceride accumulation and altered composition of triglyceride-associated fatty acids in the skin of tenascin-X-deficient mice","volume":"9","author":"Matsumoto","year":"2004","journal-title":"Genes Cells"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.7052","article-title":"Suppression of hepatic dysfunction in tenascin\u2212X\u2212deficient mice fed a high\u2212fat diet","volume":"16","author":"Yamaguchi","year":"2017","journal-title":"Mol Med Rep"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0004.2012.01858.x","article-title":"The Ehlers-Danlos syndrome, a disorder with many faces","volume":"82","author":"De Paepe","year":"2012","journal-title":"Clin Genet"},{"key":"B69","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ajmg.c.31552","article-title":"The 2017 international classification of the Ehlers-Danlos syndromes","volume":"175","author":"Malfait","year":"2017","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"B70","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41572-020-0194-9","article-title":"The Ehlers-Danlos syndromes","volume":"6","author":"Malfait","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B71","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cca.2016.05.022","article-title":"A method for quantification of serum tenascin-X by nano-LC\/MS\/MS","volume":"459","author":"Yamada","year":"2016","journal-title":"Clin Chim Acta"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12853","article-title":"Recognizing the tenascin-X deficient type of Ehlers-Danlos syndrome: a cross-sectional study in 17 patients","volume":"91","author":"Demirdas","year":"2017","journal-title":"Clin Genet"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12829","article-title":"Recurrent gastrointestinal perforation in a patient with Ehlers-Danlos syndrome due to tenascin-X deficiency","volume":"42","author":"Sakiyama","year":"2015","journal-title":"J Dermatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-0850-1","article-title":"Classical-like Ehlers-Danlos syndrome: a clinical description of 20 newly identified individuals with evidence of tissue fragility","volume":"22","author":"Green","year":"2020","journal-title":"Genet Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2009.12.026","article-title":"Pain in Ehlers-Danlos syndrome is common, severe, and associated with functional impairment","volume":"40","author":"Voermans","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1369\/0022155415627681","article-title":"TGF-\u03b2\/SMAD pathway and its regulation in hepatic fibrosis","volume":"64","author":"Xu","year":"2016","journal-title":"J Histochem Cytochem"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2012121148","article-title":"TNXB mutations can cause vesicoureteral reflux","volume":"24","author":"Gbadegesin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.30441","article-title":"Association study between the TNXB locus and schizophrenia in a Japanese population","author":"Tochigi","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"B79","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s10038-007-0219-1","article-title":"Identification of a significant association of a single nucleotide polymorphism in TNXB with systemic lupus erythematosus in a Japanese population","volume":"53","author":"Kamatani","year":"2008","journal-title":"J Hum Genet"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00283","article-title":"Tenascin-C and mechanotransduction in the development and diseases of cardiovascular system","volume":"5","author":"Imanaka-Yoshida","year":"2014","journal-title":"Front Physiol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.190546","article-title":"Tenascin-C at a glance","volume":"129","author":"Midwood","year":"2016","journal-title":"J Cell Sci"},{"key":"B82","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.112.22.3847","article-title":"The tenascin-C knockout revisited","volume":"112","author":"Mackie","year":"1999","journal-title":"J Cell Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-011-0783-6","article-title":"Advances in tenascin-C biology","volume":"68","author":"Midwood","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"B84","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12079-009-0075-1","article-title":"The role of tenascin-C in tissue injury and tumorigenesis","volume":"3","author":"Midwood","year":"2009","journal-title":"J Cell Commun Signal"},{"key":"B85","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1369\/0022155418757443","article-title":"Internal affairs: tenascin-C as a clinically relevant, endogenous driver of innate immunity","volume":"66","author":"Marzeda","year":"2018","journal-title":"J Histochem Cytochem"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.4161\/19336918.2014.994901","article-title":"Tenascins in fibrotic disorders-from bench to bedside","volume":"9","author":"Kasprzycka","year":"2015","journal-title":"Cell Adh Migr"},{"key":"B87","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/path.2099","article-title":"Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice","volume":"211","author":"El-Karef","year":"2007","journal-title":"J Pathol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00385.2009","article-title":"Tenascin-C deficiency attenuates TGF-\u00df-mediated fibrosis following murine lung injury","volume":"299","author":"Carey","year":"2010","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.11.6431","article-title":"The alternatively spliced domain TnFnIII A1A2 of the extracellular matrix protein tenascin-C suppresses activation-induced T lymphocyte proliferation and cytokine production","volume":"167","author":"Puente Navazo","year":"2001","journal-title":"J Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1998.00401.x","article-title":"Effect of tenascin-C deficiency on chemically induced dermatitis in the mouse","volume":"111","author":"Koyama","year":"1998","journal-title":"J Invest Dermatol"},{"key":"B91","article-title":"Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture","volume":"152","author":"Nakao","year":"1998","journal-title":"Am J Pathol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4161\/19336918.2014.987587","article-title":"Tenascin-C: Form versus function","volume":"9","author":"Giblin","year":"2015","journal-title":"Cell Adh Migr"},{"key":"B93","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/cvr\/cvr183","article-title":"The role of tenascin C in cardiovascular disease","volume":"92","author":"Golledge","year":"2011","journal-title":"Cardiovasc Res"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-12-1033","article-title":"Tenascin-C in cardiovascular tissue remodeling: from development to inflammation and repair","volume":"76","author":"Imanaka-Yoshida","year":"2012","journal-title":"Circ J"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00255.2009","article-title":"Tenascin-C may aggravate left ventricular remodeling and function after myocardial infarction in mice","volume":"298","author":"Nishioka","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12794","article-title":"Tenascin-C aggravates ventricular dilatation and angiotensin-converting enzyme activity after myocardial infarction in mice","volume":"7","author":"Santer","year":"2020","journal-title":"ESC Heart Fail"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e001052","DOI":"10.1161\/jaha.114.001052","article-title":"Tenascin-C aggravates autoimmune myocarditis via dendritic cell activation and Th17 cell differentiation","volume":"3","author":"Machino-Ohtsuka","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001628","article-title":"Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis","volume":"36","author":"Podesser","year":"2018","journal-title":"J Hypertens"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e318033dfd4","article-title":"Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation","volume":"49","author":"Nishioka","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvx221","article-title":"Local production of tenascin-C acts as a trigger for monocyte\/macrophage recruitment that provokes cardiac dysfunction","volume":"114","author":"Abbadi","year":"2018","journal-title":"Cardiovasc Res"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.115.06004","article-title":"Tenascin-C may accelerate cardiac fibrosis by activating macrophages via the integrin \u03b1V\u03b23\/nuclear factor-\u03baB\/interleukin-6 axis","volume":"66","author":"Shimojo","year":"2015","journal-title":"Hypertension"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.07.789","article-title":"Bone marrow-derived tenascin-C attenuates cardiac hypertrophy by controlling inflammation","volume":"70","author":"Song","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.08.014","article-title":"Tenascin-C in cardiac hypertrophy and fibrosis: friend or foe","volume":"70","author":"Park","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10059-012-0054-x","article-title":"Tenascin-C produced by oxidized LDL-stimulated macrophages increases foam cell formation through Toll-like receptor-4","volume":"34","author":"Liu","year":"2012","journal-title":"Mol Cells"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2013.01.039","article-title":"Tenascin-C deficiency in Apo E-\/- mouse increases eotaxin levels: implications for atherosclerosis","volume":"227","author":"Wang","year":"2013","journal-title":"Atherosclerosis"},{"key":"B106","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.carpath.2011.12.005","article-title":"Deletion of tenascin-C gene exacerbates atherosclerosis and induces intraplaque hemorrhage in Apo-E-deficient mice","volume":"21","author":"Wang","year":"2012","journal-title":"Cardiovasc Pathol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s12975-014-0352-z","article-title":"Gellan sulfate core platinum coil with tenascin-C promotes intra-aneurysmal organization in rats","volume":"5","author":"Hamada","year":"2014","journal-title":"Transl Stroke Res"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.177721","article-title":"Tenascin-C in aneurysmal subarachnoid hemorrhage: deleterious or protective","volume":"11","author":"Suzuki","year":"2016","journal-title":"Neural Regener Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-017-0466-x","article-title":"Effects of tenascin-C knockout on cerebral vasospasm after experimental subarachnoid hemorrhage in mice","volume":"55","author":"Fujimoto","year":"2018","journal-title":"Mol Neurobiol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2012.01.005","article-title":"Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats","volume":"46","author":"Shiba","year":"2012","journal-title":"Neurobiol Dis"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/srep04051","article-title":"Tenascin C protects aorta from acute dissection in mice","volume":"4","author":"Kimura","year":"2014","journal-title":"Sci Rep"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2011.02699.x","article-title":"Tenascin-C is expressed in abdominal aortic aneurysm tissue with an active degradation process","volume":"61","author":"Kimura","year":"2011","journal-title":"Pathol Int"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.03.033","article-title":"Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction","volume":"47","author":"Sato","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/path.1730","article-title":"Diagnostic utility of tenascin-C for evaluation of the activity of human acute myocarditis","volume":"205","author":"Morimoto","year":"2005","journal-title":"J Pathol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2008.12.017","article-title":"High prevalence of chronic myocarditis in dilated cardiomyopathy referred for left ventriculoplasty: expression of tenascin C as a possible marker for inflammation","volume":"40","author":"Tsukada","year":"2009","journal-title":"Hum Pathol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2011.11.008","article-title":"Serum tenascin-C levels as a prognostic biomarker of heart failure events in patients with hypertrophic cardiomyopathy","volume":"59","author":"Kitaoka","year":"2012","journal-title":"J Cardiol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1253\/circj.71.327","article-title":"Higher serum tenascin-C levels reflect the severity of heart failure, left ventricular dysfunction and remodeling in patients with dilated cardiomyopathy","volume":"71","author":"Terasaki","year":"2007","journal-title":"Circ J"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2020.1810319","article-title":"Plasma Tenascin-C: a prognostic biomarker in heart failure with preserved ejection fraction","volume":"25","author":"Kanagala","year":"2020","journal-title":"Biomarkers"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1159\/000233246","article-title":"Pressure overload-induced right ventricular failure is associated with re-expression of myocardial tenascin-C and elevated plasma tenascin-C levels","volume":"24","author":"Hessel","year":"2009","journal-title":"Cell Physiol Biochem"},{"key":"B120","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.cardfail.2009.06.443","article-title":"Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure","volume":"15","author":"Fujimoto","year":"2009","journal-title":"J Card Fail"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2007.07.007","article-title":"Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels","volume":"9","author":"Hessel","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-16-0563","article-title":"Serum tenascin-C as a novel predictor for risk of coronary artery lesion and resistance to intravenous immunoglobulin in Kawasaki disease- a multicenter retrospective study","volume":"80","author":"Okuma","year":"2016","journal-title":"Circ J"},{"key":"B123","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.carpath.2018.10.005","article-title":"Expression of tenascin C in cardiovascular lesions of Kawasaki disease","volume":"38","author":"Yokouchi","year":"2019","journal-title":"Cardiovasc Pathol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-014-9586-5","article-title":"Diagnostic value of strain echocardiography, galectin-3, and tenascin-C levels for the identification of patients with pulmonary and cardiac sarcoidosis","volume":"192","author":"Kul","year":"2014","journal-title":"Lung"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.99.10.1284","article-title":"Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque","volume":"99","author":"Wallner","year":"1999","journal-title":"Circulation"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/s0741-5214(97)70068-5","article-title":"Tenascin expression is associated with a chronic inflammatory process in abdominal aortic aneurysms","volume":"26","author":"Satta","year":"1997","journal-title":"J Vasc Surg"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.5551\/jat.42887","article-title":"Tenascin C: a potential biomarker for predicting the severity of coronary atherosclerosis","volume":"26","author":"Gao","year":"2019","journal-title":"J Atheroscler Thromb"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.18-462","article-title":"The role of serum tenascin-C in predicting in-hospital death in acute aortic dissection","volume":"60","author":"Guo","year":"2019","journal-title":"Int Heart J"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivt204","article-title":"Type A dissection and chronic dilatation: tenascin-C as a key factor in destabilization of the aortic wall","volume":"17","author":"Trescher","year":"2013","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.05.009","article-title":"Impact of serum tenascin-C on the aortic healing process during the chronic stage of type B acute aortic dissection","volume":"191","author":"Nozato","year":"2015","journal-title":"Int J Cardiol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1097\/ANA.0b013e31822aa1f2","article-title":"Cerebrospinal fluid tenascin-C in cerebral vasospasm after aneurysmal subarachnoid hemorrhage","volume":"23","author":"Suzuki","year":"2011","journal-title":"J Neurosurg Anesthesiol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2010.11.038","article-title":"High circulating levels of large splice variants of tenascin-C is associated with mortality and cardiovascular disease in chronic kidney disease patients","volume":"215","author":"Liabeuf","year":"2011","journal-title":"Atherosclerosis"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05108-5","article-title":"Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohort","volume":"63","author":"Gellen","year":"2020","journal-title":"Diabetologia"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000027823.07104.86","article-title":"Detection of experimental autoimmune myocarditis in rats by 111In monoclonal antibody specific for tenascin-C","volume":"106","author":"Sato","year":"2002","journal-title":"Circulation"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.17-734","article-title":"Successful inflammation imaging of non-human primate hearts using an antibody specific for tenascin-C","volume":"60","author":"Ageyama","year":"2019","journal-title":"Int Heart J"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.1996.271.2.L208","article-title":"Tenascin synthesis, deposition, and isoforms in monocrotaline-induced pulmonary hypertensive rat lungs","volume":"271","author":"Lipke","year":"1996","journal-title":"Am J Physiol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112371","article-title":"Increased serum levels of fetal tenascin-C variants in patients with pulmonary hypertension: novel biomarkers reflecting vascular remodeling and right ventricular dysfunction","volume":"18","author":"Rohm","year":"2017","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.609752\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T16:09:43Z","timestamp":1669910983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2020.609752\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":137,"alternative-id":["10.3389\/fimmu.2020.609752"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.609752","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,1]]},"article-number":"609752"}}